SFG
GSK icon

SevenBridge Financial Group’s GSK GSK Stock Holding History

SevenBridge Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,134
Closed -$225K – 147
2022
Q1 		$225K Sell
4,134
-757
-15% -$41.1K 0.08% 144
2021
Q4 		$270K Sell
4,891
-240
-5% -$12.5K 0.08% 147
2021
Q3 		$245K Hold
5,131
– – 0.08% 153
2021
Q2 		$255K Sell
5,131
-480
-9% -$23.1K 0.08% 149
2021
Q1 		$250K Buy
5,611
+217
+4% +$9.85K 0.09% 140
2020
Q4 		$248K Buy
+5,394
New +$248K 0.1% 138
2019
Q3 		– Sell
-2,598
Closed -$130K – 312
2019
Q2 		$130K Buy
2,598
+528
+26% +$26.5K 0.05% 184
2019
Q1 		$108K Hold
2,070
– – 0.04% 175
2018
Q4 		$99K Sell
2,070
-100
-5% -$4.92K 0.06% 158
2018
Q3 		$109K Sell
2,170
-120
-5% -$6.1K 0.06% 165
2018
Q2 		$115K Hold
2,290
– – 0.06% 168
2018
Q1 		$112K Buy
2,290
+412
+22% +$19.2K 0.06% 176
2017
Q4 		$83K Sell
1,878
-380
-17% -$17.6K 0.05% 205
2017
Q3 		$115K Hold
2,258
– – 0.07% 174
2017
Q2 		$123K Buy
2,258
+410
+22% +$21.9K 0.08% 169
2017
Q1 		$96K Sell
1,848
-640
-26% -$32.5K 0.06% 179
2016
Q4 		$132K Hold
2,488
– – 0.1% 161
2016
Q3 		$132K Buy
2,488
+353
+17% +$19.4K 0.1% 160
2016
Q2 		$116K Buy
+2,135
New +$112K 0.08% 181

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

SevenBridge Financial Group's GSK Position: Q2 2022 in Review

SevenBridge Financial Group sold out of GSK (GSK) in Q2 2022, closing a stake of 4,134 shares — an estimated $225K sold.

SevenBridge Financial Group first reported a position in GSK in Q2 2016 and held it in 19 quarters. The position peaked at $270K in Q4 2021. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • SevenBridge Financial Group reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • SevenBridge Financial Group sold 4,134 GSK shares in Q2 2022, an estimated $225K.
  • SevenBridge Financial Group first reported a position in GSK in Q2 2016 and held it in 19 quarters.
  • SevenBridge Financial Group's GSK position peaked at $270K in Q4 2021.
  • 900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on SevenBridge Financial Group's 13F filing for Q2 2022, filed 12 Jul 2022.